Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity.
Adolescent
Amino Acids, Branched-Chain
/ blood
Biomarkers
/ blood
Body Mass Index
Child
Child, Preschool
Chromatography, High Pressure Liquid
Female
Gas Chromatography-Mass Spectrometry
Humans
Lipids
/ blood
Male
Metabolomics
/ methods
Pediatric Obesity
/ blood
Phosphatidylcholines
/ blood
Poland
Tandem Mass Spectrometry
childhood obesity
lipidomics
obesity biomarkers
obesity pathogenesis
obesity pathomechanisms
untargeted metabolomics
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
04 Jan 2022
04 Jan 2022
Historique:
received:
16
12
2021
revised:
29
12
2021
accepted:
31
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
22
1
2022
Statut:
epublish
Résumé
Obesity rates among children are growing rapidly worldwide, placing massive pressure on healthcare systems. Untargeted metabolomics can expand our understanding of the pathogenesis of obesity and elucidate mechanisms related to its symptoms. However, the metabolic signatures of obesity in children have not been thoroughly investigated. Herein, we explored metabolites associated with obesity development in childhood. Untargeted metabolomic profiling was performed on fasting serum samples from 27 obese Caucasian children and adolescents and 15 sex- and age-matched normal-weight children. Three metabolomic assays were combined and yielded 726 unique identified metabolites: gas chromatography-mass spectrometry (GC-MS), hydrophilic interaction liquid chromatography coupled to mass spectrometry (HILIC LC-MS/MS), and lipidomics. Univariate and multivariate analyses showed clear discrimination between the untargeted metabolomes of obese and normal-weight children, with 162 significantly differentially expressed metabolites between groups. Children with obesity had higher concentrations of branch-chained amino acids and various lipid metabolites, including phosphatidylcholines, cholesteryl esters, triglycerides. Thus, an early manifestation of obesity pathogenesis and its metabolic consequences in the serum metabolome are correlated with altered lipid metabolism. Obesity metabolite patterns in the adult population were very similar to the metabolic signature of childhood obesity. Identified metabolites could be potential biomarkers and used to study obesity pathomechanisms.
Identifiants
pubmed: 35011090
pii: nu14010214
doi: 10.3390/nu14010214
pmc: PMC8747180
pii:
doi:
Substances chimiques
Amino Acids, Branched-Chain
0
Biomarkers
0
Lipids
0
Phosphatidylcholines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical University of Bialystok
ID : 56/KNOW/15
Organisme : Medical University of Bialystok
ID : N/ST/MN/18/004/1109
Références
Nat Med. 1997 May;3(5):562-6
pubmed: 9142128
Clin Biochem. 2016 Jul;49(10-11):740-9
pubmed: 26948098
BMJ. 2000 May 6;320(7244):1240-3
pubmed: 10797032
Am J Clin Nutr. 2015 Aug;102(2):256-67
pubmed: 26085512
J Obes Metab Syndr. 2018 Sep 30;27(3):143-149
pubmed: 31089556
Am J Clin Nutr. 2005 Oct;82(4):747-50
pubmed: 16210702
J Transl Med. 2018 Jun 26;16(1):175
pubmed: 29940972
Nat Rev Endocrinol. 2014 Dec;10(12):723-36
pubmed: 25287287
Clin Chim Acta. 2016 Dec 1;463:53-61
pubmed: 27720726
Front Endocrinol (Lausanne). 2020 Sep 08;11:617
pubmed: 33013697
Sci Rep. 2021 Mar 3;11(1):5058
pubmed: 33658594
Curr Obes Rep. 2014 Dec;3(4):422-31
pubmed: 26626919
Nat Rev Drug Discov. 2016 Jul;15(7):473-84
pubmed: 26965202
Prog Lipid Res. 2014 Jan;53:108-23
pubmed: 24345640
Pediatr Clin North Am. 2015 Aug;62(4):821-40
pubmed: 26210619
Front Endocrinol (Lausanne). 2020 Nov 20;11:602252
pubmed: 33329402
Nat Methods. 2015 Jun;12(6):523-6
pubmed: 25938372
Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:8-17
pubmed: 22922020
Sci Rep. 2017 Jul 24;7(1):6335
pubmed: 28740130
FASEB J. 2011 Oct;25(10):3436-47
pubmed: 21697548
Chem Phys Lipids. 2018 Nov;216:114-131
pubmed: 30194926
Metabolomics. 2007 Sep;3(3):211-221
pubmed: 24039616
Pediatr Obes. 2019 Jan;14(1):
pubmed: 30253079
J Lipid Res. 2008 May;49(5):1137-46
pubmed: 18281723
Metabolites. 2019 May 22;9(5):
pubmed: 31121816
PLoS One. 2019 Mar 5;14(3):e0213285
pubmed: 30835753
Adv Nutr. 2013 May 01;4(3):311-2
pubmed: 23674797
Nat Med. 2016 Apr;22(4):421-6
pubmed: 26950361
PLoS One. 2020 Nov 17;15(11):e0239115
pubmed: 33201881
J Proteome Res. 2019 Aug 2;18(8):3174-3183
pubmed: 31290314
Obes Rev. 2016 Feb;17(2):95-107
pubmed: 26696565
J Nutr Biochem. 2020 Dec;86:108484
pubmed: 32827665
J Clin Endocrinol Metab. 2016 Nov;101(11):4329-4337
pubmed: 27504851
Nutr Diabetes. 2014 Oct 20;4:e141
pubmed: 25329603
Nat Methods. 2013 Aug;10(8):755-8
pubmed: 23817071
Obesity (Silver Spring). 2016 Apr;24(4):908-16
pubmed: 26916476
Methods Mol Biol. 2017;1609:149-170
pubmed: 28660581
Diabetologia. 2016 Nov;59(11):2349-2359
pubmed: 27514531
Metabolites. 2018 May 10;8(2):
pubmed: 29748461
Pharmacol Rev. 2014 Oct;66(4):1106-40
pubmed: 25244930
Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt B):1558-1572
pubmed: 28411170
Circ Res. 2016 May 27;118(11):1703-5
pubmed: 27230636
Prostaglandins Other Lipid Mediat. 2016 Dec;127:9-13
pubmed: 27913146
J Membr Biol. 2017 Aug;250(4):353-366
pubmed: 27278236
Biochem Soc Trans. 2011 Apr;39(2):495-9
pubmed: 21428927
J Diabetes. 2018 May;10(5):350-352
pubmed: 29369529
Mol Cells. 2015 Jul;38(7):587-96
pubmed: 26072981
PLoS One. 2015 May 26;10(5):e0125935
pubmed: 26011530
BMC Pediatr. 2017 Apr 28;17(1):116
pubmed: 28454530
J Family Med Prim Care. 2015 Apr-Jun;4(2):187-92
pubmed: 25949965
BBA Clin. 2016 Apr 13;5:179-85
pubmed: 27182493
J Pediatr Endocrinol Metab. 2011;24(1-2):81-3
pubmed: 21528821
Nucleic Acids Res. 2021 Jul 2;49(W1):W388-W396
pubmed: 34019663
Int J Biol Sci. 2018 Aug 6;14(11):1483-1496
pubmed: 30263000
Diabetol Metab Syndr. 2014 Mar 20;6(1):40
pubmed: 24650495
Lipids Health Dis. 2019 Apr 9;18(1):94
pubmed: 30967146
Diabetologia. 2018 Apr;61(4):849-861
pubmed: 29349498
Clin Sci (Lond). 2008 Feb;114(3):183-93
pubmed: 18184112
Nutrients. 2020 May 03;12(5):
pubmed: 32375231
J Am Coll Nutr. 2003 Dec;22(6):502-10
pubmed: 14684755
Med Wieku Rozwoj. 2001 Apr-Jun;5(2 Suppl 1):18-118
pubmed: 11675534
Ann Nutr Metab. 2010;57(3-4):234-41
pubmed: 21150195
Sci Rep. 2018 Oct 3;8(1):14764
pubmed: 30282999
Mass Spectrom Rev. 2019 May;38(3):221-238
pubmed: 29073341
PLoS One. 2013 Sep 06;8(9):e72449
pubmed: 24039766
BMC Bioinformatics. 2011 Aug 04;12:321
pubmed: 21816034
Int J Genomics. 2018 Nov 19;2018:4283078
pubmed: 30581838
Obesity (Silver Spring). 2014 Dec;22(12):2570-8
pubmed: 25251340
J Clin Endocrinol Metab. 2017 Mar 1;102(3):709-757
pubmed: 28359099
PLoS Biol. 2019 Oct 18;17(10):e3000443
pubmed: 31626640
Metabolism. 2014 Jun;63(6):841-50
pubmed: 24684822
Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E398-408
pubmed: 26126684
Compr Physiol. 2017 Dec 12;8(1):1-8
pubmed: 29357123
Toxicol Appl Pharmacol. 2000 Nov 1;168(3):268-79
pubmed: 11042099
Am J Respir Cell Mol Biol. 2001 Oct;25(4):434-8
pubmed: 11694448
Diabet Med. 2018 Jun;35(6):737-744
pubmed: 29460341
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
J Nutr. 2020 Dec 10;150(12):3180-3189
pubmed: 33097955
Oxid Med Cell Longev. 2020 Aug 11;2020:2935278
pubmed: 33299523
Metabolomics. 2019 Jun 13;15(6):93
pubmed: 31197497
Child Obes. 2014 Aug;10(4):292-303
pubmed: 25055134
PLoS One. 2018 Jan 11;13(1):e0190632
pubmed: 29324762
Pediatr Obes. 2012 Aug;7(4):284-94
pubmed: 22715120
Obes Facts. 2012;5(5):660-70
pubmed: 23108202
J Biol Chem. 2001 Sep 28;276(39):36059-62
pubmed: 11451964
Obes Rev. 2013 Aug;14(8):659-64
pubmed: 23679666
BMC Endocr Disord. 2021 Oct 13;21(1):201
pubmed: 34641844
Front Med (Lausanne). 2016 Nov 25;3:57
pubmed: 27933294